Equity Investees (Tables)

12 Months Ended

Dec. 31, 2021

Equity Method Investments and Joint Ventures [Abstract]

Schedule of Consolidated Financial Statements Related To Equity Investees

The following table presents information included in our Consolidated Financial Statements related to our equity investees: 

	Year Ended December 31,
	2021		2020		2019
Genesis’ share of operating earnings	$	73,389	$	79,510	$	71,975
Amortization of differences attributable to Genesis' carrying value of equity investments	(15,491)		(15,491)		(15,491)
Net equity in earnings	$	57,898	$	64,019	$	56,484
Distributions received	$	84,106	$	81,061	$	77,331

Schedule of Balance Sheet Information For Equity Investees

The following tables present the combined balance sheet information for the last two years and statements of operations data for the last three years for our equity investees (on a 100% basis):

	December 31,
	2021		2020
BALANCE SHEET DATA:
Assets
Current assets	$	33,994	$	42,565
Fixed assets, net	284,265		299,315
Other assets	21,327		25,654
Total assets	$	339,586	$	367,534
Liabilities and equity
Current liabilities	$	15,457	$	13,411
Other liabilities	237,948		248,857
Equity	86,181		105,266
Total liabilities and equity	$	339,586	$	367,534

Schedule of Operations For Equity Investees

	Year Ended December 31,
	2021		2020		2019
STATEMENTS OF OPERATIONS DATA:
Revenues	$	203,835	$	214,687	$	209,674
Operating Income	$	143,506	$	153,640	$	155,920
Net Income	$	138,783	$	147,560	$	139,436